Compare Stocks → Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NYSEAMERICAN:ARMPNYSE:NFX Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeARMPArmata Pharmaceuticals$2.67+4.7%$0.00$1.07▼$5.26$96.34M0.8517,560 shs9,559 shsNFXNewfield Exploration$17.07$0.00$12.45▼$31.46$3.43B1.858.80 million shsN/AElon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceARMPArmata Pharmaceuticals0.00%0.00%0.00%0.00%0.00%NFXNewfield Exploration0.00%0.00%0.00%0.00%0.00%SHOCKING Crypto Leak… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationARMPArmata Pharmaceuticals2.096 of 5 stars3.53.00.00.01.91.70.6NFXNewfield ExplorationN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceARMPArmata Pharmaceuticals3.00Buy$7.00162.66% UpsideNFXNewfield ExplorationN/AN/AN/AN/ACurrent Analyst RatingsLatest EX1, RNO, ARMP, and NFX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/22/2024ARMPArmata PharmaceuticalsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$7.00(Data available from 4/20/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookARMPArmata Pharmaceuticals$4.53M21.27N/AN/A($0.89) per share-2.99NFXNewfield Exploration$1.77B1.94$4.50 per share3.79$7.05 per share2.42Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateARMPArmata Pharmaceuticals-$69.04M-$1.98N/AN/AN/A-1,524.51%-280.95%-52.61%5/9/2024 (Estimated)NFXNewfield Exploration$427M$2.157.945.170.3721.14%43.65%13.21%N/ALatest EX1, RNO, ARMP, and NFX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/21/2024Q4 2023ARMPArmata PharmaceuticalsN/A-$0.55-$0.55-$0.55$0.68 million$1.53 millionDividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthARMPArmata PharmaceuticalsN/AN/AN/AN/AN/ANFXNewfield ExplorationN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioARMPArmata PharmaceuticalsN/A1.161.16NFXNewfield Exploration1.300.720.70OwnershipInstitutional OwnershipCompanyInstitutional OwnershipARMPArmata Pharmaceuticals3.57%NFXNewfield Exploration97.87%Insider OwnershipCompanyInsider OwnershipARMPArmata Pharmaceuticals85.50%NFXNewfield Exploration0.59%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableARMPArmata Pharmaceuticals6636.15 million5.24 millionNot OptionableNFXNewfield ExplorationN/A200.93 millionN/AOptionableEX1, RNO, ARMP, and NFX HeadlinesSourceHeadlineOffices inspired by the era of disco musictheplan.it - March 29 at 4:18 PMNew and used 2024 Acura Integra for sale near Newfield, NJcars.com - March 23 at 2:54 AMMicrosoft could launch Surface Pro 10 and Surface Laptop 6 on March 21: Reportgizmochina.com - March 6 at 4:11 PMMicrosoft Looks to Be Muscling In on Partner Segathestreet.com - December 28 at 12:42 AMBoozy office holiday parties are going out of fashion as workers sip mocktails, non-alcoholic wine insteadmsn.com - December 22 at 9:58 PMKhosla, Tiger, NEA, and 24 other VC firms warn of ‘destructive’ impact of FTC’s current M&A approachaol.com - December 7 at 8:32 PMMana.bio Advances AI-Based Lipid Nanoparticle (LNP) Platform to Accelerate "Programmable Drug Delivery" for RNA and Gene Therapiesbenzinga.com - October 10 at 12:58 PMNewfield issues A$16.9m in new equityminingweekly.com - September 29 at 12:38 PMWhy NFX Invested in Vendict: The Startup Behind the First Cybersecurity LLMmsn.com - August 14 at 8:21 AMWill A.I. replace venture capitalists?msn.com - June 26 at 12:46 PMNewfield Stock Falls On Unusually High Volume (NFX)thestreet.com - May 28 at 12:11 AMNFX’s James Currier: Where unicorn ideas come from and why founders ‘have to keep pivoting’msn.com - May 7 at 3:15 PMNewfield High Schoolusnews.com - May 1 at 7:56 AMNewfield Hamlet, United States - Weather Forecasts | Maps | News - Yahoo Weatheryahoo.com - April 30 at 5:26 AMUtility Funds May Be Set to Outperformthestreet.com - March 10 at 7:17 PMFounder and NFX VC James Currier vets startup ideas at TC Early Stagemsn.com - January 23 at 3:07 PMThe 5 Best Half-Life: Alyx Mods for Story and Explorationescapistmagazine.com - January 12 at 6:15 PMXternity, Backed by NFX, Secures $4.5 Million To Boost Web3 Adoption by WEB2 Gamesmsn.com - November 7 at 5:04 PMNewfield Senior High Schoolusnews.com - October 18 at 11:35 PMNewfield, NY 10-Day Weather Forecastwunderground.com - October 12 at 10:54 PMNewfield, NJ Weather Conditionswunderground.com - October 11 at 4:31 PMNewfield, NY Weather Conditionswunderground.com - September 27 at 12:08 AMWest Newfield, ME Weather Conditionswunderground.com - September 10 at 6:01 PMWant more private firms to invest in mineral exploration: Govtlivemint.com - August 25 at 6:43 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsArmata PharmaceuticalsNYSEAMERICAN:ARMPArmata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is headquartered in Los Angeles, California.Newfield ExplorationNYSE:NFXNewfield Exploration Company, an independent energy company, engages in the exploration, development, and production of crude oil, natural gas, and natural gas liquids in the United States. The company has operations principally in the Anadarko and Arkoma basins of Oklahoma, the Williston Basin of North Dakota, and the Uinta Basin of Utah. It also holds oil producing assets offshore China. The company was founded in 1988 and is headquartered in The Woodlands, Texas. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.